[ad_1]
Dua A, Lee CJ. Epidemiology of peripheral arterial illness and significant limb ischemia. Tech Vasc Interv Radiol. 2016;19:91–5. https://doi.org/10.1053/j.tvir.2016.04.001.
Levin SR, Arinze N, Siracuse JJ. Decrease extremity important limb ischemia: a evaluation of scientific options and administration. Developments Cardiovasc Med. 2020;30:125–30. https://doi.org/10.1016/j.tcm.2019.04.002.
Annex BH. Therapeutic angiogenesis for important limb ischaemia. Nat Rev Cardiol. 2013;10:387–96. https://doi.org/10.1038/nrcardio.2013.70.
Huang A, Liu D, Qi X, Yue Z, Cao H, Zhang Ok, et al. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia mannequin. Acta Biomater. 2019;85:94–105. https://doi.org/10.1016/j.actbio.2018.12.015.
Pizzimenti M, Riou M, Charles AL, Talha S, Meyer A, Andres E, et al. The rise of mitochondria in peripheral arterial illness physiopathology: experimental and scientific knowledge. J Clin Med. 2019;8:2125. https://doi.org/10.3390/jcm8122125.
Figliolini F, Ranghino A, Grange C, Cedrino M, Tapparo M, Cavallari C, et al. Extracellular vesicles from adipose stem cells stop muscle injury and irritation in a mouse mannequin of hind limb ischemia: position of neuregulin-1. Arterioscler Thromb Vasc Biol. 2020;40:239–54. https://doi.org/10.1161/ATVBAHA.119.313506.
Kim S, Piao J, Hwang DY, Park JS, Son Y, Hong HS. Substance P accelerates wound restore by selling neovascularization and stopping irritation in an ischemia mouse mannequin. Life Sci. 2019;225:98–106. https://doi.org/10.1016/j.lfs.2019.04.015.
Bose RJ, Kim BJ, Arai Y, Han IB, Moon JJ, Paulmurugan R, et al. Bioengineered stem cell membrane functionalized nanocarriers for therapeutic concentrating on of extreme hindlimb ischemia. Biomaterials. 2018;185:360–70. https://doi.org/10.1016/j.biomaterials.2018.08.018.
Olguin HC, Pisconti A. Marking the tempo for myogenesis: Pax7 and the regulation of muscle stem cell destiny choices. J Cell Mol Med. 2012;16:1013–25. https://doi.org/10.1111/j.1582-4934.2011.01348.x.
Zammit PS. Operate of the myogenic regulatory components Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite tv for pc cells and regenerative myogenesis. Semin Cell Dev Biol. 2017;72:19–32. https://doi.org/10.1016/j.semcdb.2017.11.011.
Yamamoto M, Legendre NP, Biswas AA, Lawton A, Yamamoto S, Tajbakhsh S, et al. Lack of MyoD and Myf5 in skeletal muscle stem cells ends in altered myogenic programming and failed regeneration. Stem Cell Rep. 2018;10:956–69. https://doi.org/10.1016/j.stemcr.2018.01.027.
Legler DF, Bruckner M, Uetz-von Allmen E, Krause P. Prostaglandin E2 at new look: novel insights in useful range provide therapeutic possibilities. Int J Biochem Cell Biol. 2010;42:198–201. https://doi.org/10.1016/j.biocel.2009.09.015.
Cheng H, Huang H, Guo Z, Chang Y, Li Z. Function of prostaglandin E2 in tissue restore and regeneration. Theranostics. 2021;11:8836–54. https://doi.org/10.7150/thno.63396.
Cao X, Duan L, Hou H, Liu Y, Chen S, Zhang S, et al. IGF-1C hydrogel improves the therapeutic results of MSCs on colitis in mice by PGE2-mediated M2 macrophage polarization. Theranostics. 2020;10:7697–709. https://doi.org/10.7150/thno.45434.
Zhang S, Liu Y, Zhang X, Zhu D, Qi X, Cao X, et al. Prostaglandin E2 hydrogel improves cutaneous wound therapeutic by way of M2 macrophages polarization. Theranostics. 2018;8:5348–61. https://doi.org/10.7150/thno.27385.
Zhu Z, Fu C, Li X, Tune Y, Li C, Zou M, et al. Prostaglandin E2 promotes endothelial differentiation from bone marrow-derived cells by AMPK activation. PLoS ONE. 2011;6: e23554. https://doi.org/10.1371/journal.pone.0023554.
Brochhausen C, Zehbe R, Watzer B, Halstenberg S, Gabler F, Schubert H, et al. Immobilization and managed launch of prostaglandin E2 from poly-l-lactide-co-glycolide microspheres. J Biomed Mater Res A. 2009;91:454–62. https://doi.org/10.1002/jbm.a.32215.
Yoo SY, Kwon SM. Angiogenesis and its therapeutic alternatives. Mediators Inflamm. 2013;2013: 127170. https://doi.org/10.1155/2013/127170.
Ho ATV, Palla AR, Blake MR, Yucel ND, Wang YX, Magnusson KEG, et al. Prostaglandin E2 is crucial for efficacious skeletal muscle stem-cell perform, augmenting regeneration and power. Proc Natl Acad Sci USA. 2017;114:6675–84. https://doi.org/10.1073/pnas.1705420114.
Yu D, Cai Z, Li D, Zhang Y, He M, Yang Y, et al. Myogenic differentiation of stem cells for skeletal muscle regeneration. Stem Cells Int. 2021;2021:8884283. https://doi.org/10.1155/2021/8884283.
Bondesen BA, Mills ST, Kegley KM, Pavlath GK. The COX-2 pathway is crucial throughout early phases of skeletal muscle regeneration. Am J Physiol Cell Physiol. 2004;287:C475–83. https://doi.org/10.1152/ajpcell.00088.2004.
Agarwal Ok, Batra A, Batra A, Aggarwal A. Randomized comparability of isosorbide mononitrate and PGE2 gel for cervical ripening at time period together with excessive danger being pregnant. Int J Reprod Med. 2014;2014: 147274. https://doi.org/10.1155/2014/147274.
Leitinger B, Hohenester E. Mammalian collagen receptors. Matrix Biol. 2007;26:146–55. https://doi.org/10.1016/j.matbio.2006.10.007.
An B, Lin YS, Brodsky B. Collagen interactions: drug design and supply. Adv Drug Deliv Rev. 2016;97:69–84. https://doi.org/10.1016/j.addr.2015.11.013.
Wallace DG, Rosenblatt J. Collagen gel programs for sustained supply and tissue engineering. Adv Drug Deliv Rev. 2003;55:1631–49. https://doi.org/10.1016/j.addr.2003.08.004.
Wang T, Yu X, Han L, Liu T, Liu Y, Zhang N. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for environment friendly co-delivery of doxorubicin and plasmid DNA. Int J Nanomed. 2017;12:4773–88. https://doi.org/10.2147/IJN.S134378.
Lee AS, Inayathullah M, Lijkwan MA, Zhao X, Solar W, Park S, et al. Extended survival of transplanted stem cells after ischaemic harm by way of the sluggish launch of pro-survival peptides from a collagen matrix. Nat Biomed Eng. 2018;2:104–13. https://doi.org/10.1038/s41551-018-0191-4.
Luo Z, Wang S, Zhang S. Fabrication of self-assembling D-form peptide nanofiber scaffold d-EAK16 for speedy hemostasis. Biomaterials. 2011;32:2013–20. https://doi.org/10.1016/j.biomaterials.2010.11.049.
Feng G, Zhang J, Li Y, Nie Y, Zhu D, Wang R, et al. IGF-1 C domain-modified hydrogel enhances cell remedy for AKI. J Am Soc Nephrol. 2016;27:2357–69. https://doi.org/10.1681/ASN.2015050578.
Niiyama H, Huang NF, Rollins MD, Cooke JP. Murine mannequin of hindlimb ischemia. JoVE. 2009;1035. https://doi.org/10.3791/1035.
Zhang Ok, Chen X, Li H, Feng G, Nie Y, Wei Y, et al. A nitric oxide-releasing hydrogel for enhancing the therapeutic results of mesenchymal stem cell remedy for hindlimb ischemia. Acta Biomater. 2020;113:289–304. https://doi.org/10.1016/j.actbio.2020.07.011.
Wang X, Jin J, Hou R, Zhou M, Mou X, Xu Ok, et al. Differentiation of bMSCs on biocompatible, biodegradable, and biomimetic scaffolds for largely defected tissue restore. ACS Appl Bio Mater. 2020;3:735–46. https://doi.org/10.1021/acsabm.9b01063.
Du W, Zhang Ok, Zhang S, Wang R, Nie Y, Tao H, et al. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer. Biomaterials. 2017;133:70–81. https://doi.org/10.1016/j.biomaterials.2017.04.030.
Zhang Ok, Zhao X, Chen X, Wei Y, Du W, Wang Y, et al. Enhanced therapeutic results of mesenchymal stem cell-derived exosomes with an injectable hydrogel for hindlimb ischemia therapy. ACS Appl Mater Interfaces. 2018;10:30081–91. https://doi.org/10.1021/acsami.8b08449.
Zhang Ok, Wang C, Wang R, Chen S, Li Z. Twin bioluminescence imaging of tumor development and angiogenesis. JoVE. 2019;e59763. https://doi.org/10.3791/59763.
Oommen OP, Wang SJ, Kisiel M, Sloff M, Hilborn J, Varghese OP. Sensible design of steady extracellular matrix mimetic hydrogel: synthesis, characterization, and in vitro and in vivo analysis for tissue engineering. Adv Funct Mater. 2013;23:1273–80. https://doi.org/10.1002/adfm.201201698.
Kubler M, Beck S, Fischer S, Gotz P, Kumaraswami Ok, Ishikawa-Ankerhold H, et al. Absence of cold-inducible RNA-binding protein (CIRP) promotes angiogenesis and regeneration of ischemic tissue by inducing M2-like macrophage polarization. Biomedicines. 2021;9:395. https://doi.org/10.3390/biomedicines9040395.
Frangogiannis NG. Cell remedy for peripheral artery illness. Curr Opin Pharmacol. 2018;39:27–34. https://doi.org/10.1016/j.coph.2018.01.005.
Wu H, Ren Y, Li S, Wang W, Yuan J, Guo X, et al. In vitro tradition and induced differentiation of sheep skeletal muscle satellite tv for pc cells. Cell Biol Int. 2012;36:579–87. https://doi.org/10.1042/CBI20110487.
Fuke M, Narita M, Wada Y, Seto T, Okada Ok, Nakayama J, et al. Elevated expression of Y-Field-binding protein-1 in hind-limb muscle tissue throughout regeneration from ischemic harm in mice. Tohoku J Exp Med. 2018;244:53–62. https://doi.org/10.1620/tjem.244.53.
Howard EE, Pasiakos SM, Blesso CN, Fussell MA, Rodriguez NR. Divergent roles of irritation in skeletal muscle restoration from harm. Entrance Physiol. 2020;11:87. https://doi.org/10.3389/fphys.2020.00087.
Martinez-Colon GJ, Moore BB. Prostaglandin E2 as a regulator of Immunity to pathogens. Pharmacol Ther. 2018;185:135–46. https://doi.org/10.1016/j.pharmthera.2017.12.008.
Chen S, Huang H, Liu Y, Wang C, Chen X, Chang Y, et al. Renal subcapsular supply of PGE2 promotes kidney restore by activating endogenous Sox9(+) stem cells. iScience. 2021;24:103243. https://doi.org/10.1016/j.isci.2021.103243.
Cui Z, Yang BF, Li RK. Utility of biomaterials in cardiac restore and regeneration. Engineering. 2016;2:141–8. https://doi.org/10.1016/J.Eng.2016.01.028.
Choudhury D, Tun HW, Wang T, Naing MW. Organ-derived decellularized extracellular matrix: a recreation changer for bioink manufacturing? Developments Biotechnol. 2018;36:787–805. https://doi.org/10.1016/j.tibtech.2018.03.003.
Kato N, Hasegawa U, Morimoto N, Saita Y, Nakashima Ok, Ezura Y, et al. Nanogel-based supply system enhances PGE2 results on bone formation. J Cell Biochem. 2007;101:1063–70. https://doi.org/10.1002/jcb.21160.
Friends S, Montembault A, Ladaviere C. Chitosan hydrogels for sustained drug supply. J Management Launch. 2020;326:150–63. https://doi.org/10.1016/j.jconrel.2020.06.012.
Duff S, Mafilios MS, Bhounsule P, Hasegawa JT. The burden of important limb ischemia: a evaluation of latest literature. Vasc Well being Danger Manag. 2019;15:187–208. https://doi.org/10.2147/VHRM.S209241.
Fabre JE, Nguyen M, Athirakul Ok, Coggins Ok, McNeish JD, Austin S, et al. Activation of the murine EP3 receptor for PGE2 inhibits cAMP manufacturing and promotes platelet aggregation. J Clin Make investments. 2001;107:603–10. https://doi.org/10.1172/JCI10881.
Zhang J, Wang JH. Prostaglandin E2 (PGE2) exerts biphasic results on human tendon stem cells. PLoS ONE. 2014;9: e87706. https://doi.org/10.1371/journal.pone.0087706.
Li M, Wang Y, Liu M, Lan X. Multimodality reporter gene imaging: building methods and software. Theranostics. 2018;8:2954–73. https://doi.org/10.7150/thno.24108.
Massoud TF, Gambhir SS. Molecular imaging in residing topics: seeing basic organic processes in a brand new gentle. Genes Dev. 2003;17:545–80. https://doi.org/10.1101/gad.1047403.
Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, Lichtman JW, et al. Useful muscle regeneration with mixed supply of angiogenesis and myogenesis components. Proc Natl Acad Sci USA. 2010;107:3287–92. https://doi.org/10.1073/pnas.0903875106.
Angst E, Chen M, Mojadidi M, Hines OJ, Reber HA, Eibl G. Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic most cancers mannequin. Mol Imaging Biol. 2010;12:570–5. https://doi.org/10.1007/s11307-010-0310-4.
Norooznezhad AH, Norooznezhad F. Cannabinoids: doable brokers for therapy of psoriasis by way of suppression of angiogenesis and irritation. Med Hypotheses. 2017;99:15–8. https://doi.org/10.1016/j.mehy.2016.12.003.
Matsushita J, Inagaki S, Nishie T, Sakasai T, Tanaka J, Watanabe C, et al. Fluorescence and bioluminescence imaging of angiogenesis in Flk1-nano-lantern transgenic mice. Sci Rep. 2017;7:46597. https://doi.org/10.1038/srep46597.
Ouyang J, Ji X, Zhang X, Feng C, Tang Z, Kong N, et al. In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer therapy. Proc Natl Acad Sci USA. 2020;117:28667. https://doi.org/10.1073/pnas.2016268117.
Coultas L, Chawengsaksophak Ok, Rossant J. Endothelial cells and VEGF in vascular growth. Nature. 2005;438:937–45. https://doi.org/10.1038/nature04479.
DeQuach JA, Lin JE, Cam C, Hu D, Salvatore MA, Sheikh F, et al. Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia mannequin. Eur Cell Mater. 2012;23:400–12. https://doi.org/10.22203/ecm.v023a31.
Kanisicak O, Mendez JJ, Yamamoto S, Yamamoto M, Goldhamer DJ. Progenitors of skeletal muscle satellite tv for pc cells categorical the muscle dedication gene, MyoD. Dev Biol. 2009;332:131–41. https://doi.org/10.1016/j.ydbio.2009.05.554.
Paoni NF, Peale F, Wang F, Errett-Baroncini C, Steinmetz H, Toy Ok, et al. Time course of skeletal muscle restore and gene expression following acute hind limb ischemia in mice. Physiol Genomics. 2002;11:263–72. https://doi.org/10.1152/physiolgenomics.00110.2002.
Nakagawa T, Miyagawa S, Shibuya T, Sakai Y, Harada A, Watanabe Ok, et al. Administration of slow-release artificial prostacyclin agonist promoted angiogenesis and skeletal muscle regeneration for limb ischemia. Mol Ther Strategies Clin Dev. 2020;18:119–30. https://doi.org/10.1016/j.omtm.2020.05.022.
Mo C, Romero-Suarez S, Bonewald L, Johnson M, Brotto M. Prostaglandin E2: from scientific purposes to its potential position in bone-muscle crosstalk and myogenic differentiation. Latest Pat Biotechnol. 2012;6:223–9. https://doi.org/10.2174/1872208311206030223.
He N, Xu Y, Du W, Qi X, Liang L, Wang Y, et al. Extracellular matrix can recuperate the downregulation of adhesion molecules after cell detachment and improve endothelial cell engraftment. Sci Rep. 2015;5:10902. https://doi.org/10.1038/srep10902.
Parekh G, Shi Y, Zheng J, Zhang X, Leporatti S. Nano-carriers for focused supply and biomedical imaging enhancement. Ther Deliv. 2018;9:451–68. https://doi.org/10.4155/tde-2018-0013.
[ad_2]
